Skip to main content
Biomind Labs logo

Biomind Labs — Investor Relations & Filings

Ticker · BMND ISIN · CA0907021012 LEI · 254900YBPPG0XSZOE887 NEO Professional, scientific and technical activities
Filings indexed 196 across all filing types
Latest filing 2020-01-08 AGM Information
Country CA Canada
Listing NEO BMND

About Biomind Labs

https://www.biomindlabs.com/

Biomind Labs is a biotechnology research and development company focused on creating novel pharmaceutical drugs for patients suffering from neurological and psychiatric disorders. The company employs an R&D acceleration platform to develop next-generation formulations, including those based on key endogenous substances. A core technological focus is the integration of nanotech delivery systems to target the underlying drivers of disease.

Recent filings

Filing Released Lang Actions
Letter from former auditor.pdf
AGM Information Classification · 95% confidence The document is a Form of Proxy for an Annual General and Special Meeting scheduled on February 5, 2020. It includes instructions for appointing a proxyholder, voting on the number of directors, election of directors, appointment of auditors, and approval of a stock option plan. The content is focused on soliciting votes and providing proxy voting instructions for the AGM, rather than presenting financial data or detailed reports. Therefore, this document fits the category of AGM Information, which includes presentations and materials shared during the Annual General Meeting.
2020-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.